Veterinary Medicines

Lamulin 364.2 mg/g granules for oral solutionfor pigs

Not authorised
  • Tiamulin
Download as PDF

Product identification

Medicine name:
Lamulin 364.2 mg/g granules for oral solutionfor pigs
Stalimox 364,2 mg/g granule na prípravu perorálneho roztoku pre ošípané
Active substance:
  • Tiamulin
Target species:
  • Pig
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Tiamulin
    364.20
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Granules for oral solution
Withdrawal period by route of administration:
  • Oral use
    • Pig
      • Meat and offal
        2
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XQ01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Slovakia
Package description:
  • 100 g polypropylene container with inner bag of LDPE.
  • 1 kg polypropylene container with inner bag of LDPE.
  • 5 kg polypropylene container with inner bag of LDPE.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lavet Kft.
  • Virbac
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/047/MR/06-S
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0102/001

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 23/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."